Advanced targeted temperature management technology to reduce brain damage in cardiac arrest patients

Technology uses body temperature management to stabilise patients

New Delhi, 5^thJanuary 2015: In a scientific program held at AIIMS, New Delhi on 5th January 2015 by the Society of Cardiac Anesthesiology in association with the American Heart Association there interesting discussions revealed newest technologies on cardiac anesthesia and patient care. One of the discussions was also on the temperature management technology that brings precision targeted temperature management to the highest level of performance available today.

The Temperature Management System is designed to monitor and control a patient's temperature within a range of 32°C to 38.5°C (89.6°F to 101.3°F).   It consists of an electronic module and disposable Gel Pads. The system includes a stand-alone electronic module with an interactive touch screen.  This is connected to the conductive pads that are placed on the patient and provide thermal-energy transfer to deliver targeted temperature management therapy to the patient. The touch screen interface quickly guides clinicians to successfully initiate treatment with a few simple steps.

Dr. Yatin Mehta who is the chairman for critical care and anesthesia at the Medanta Medicity will share his views on using the machine at the programme.

Targeted Temperature Management technology works at inducing therapeutic hyperthermia, maintaining hyperthermia , controlled rewarming and normothermia  in patients who have had a cardiac arrest with an objective to improve the neurologic outcome. This is done by defining the expected neurologic outcome in individual patients by setting target temperatures by clinicians.